 |
| L-R: First co-authors Drs Jay Jha and Jakob Østergaard, lead author Professor Karin Jandeleit-Dahm, CCS Diabetes |
by Anne Crawford
A study by Monash University Department of Diabetes researchers suggests that a new anti-inflammatory drug approach developed to counter inflammation and heart disease may be harmful to kidneys.
